{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T22:32:15Z","timestamp":1793485935604,"version":"4.5.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Voriconazole has a broader spectrum of activity in comparison to fluconazole, itraconazole, and amphotericin B. Little documentation regarding appropriate dosing, efficacy, or adverse effects exists for cats. Neurologic adverse effects have been reported as a result of administration in other species.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>Voriconazole administration resulted in neurologic abnormalities in 3 cats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Three cats that received voriconazole.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Observational study of adverse effects associated with voriconazole administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All 3 cats had ataxia, which in 2 cats progressed to paraplegia of the rear limbs. Two of the cats had visual abnormalities including mydriasis, decreased to absent pupillary light responses, and decreased menace response. Arrhythmia and hypokalemia were noted in 2 separate cats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Voriconazole has potential neurologic adverse effects in cats. Additional information regarding pharmacokinetics of the drug in this species must be gathered to help determine how it can be dosed most effectively with minimal adverse effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1939-1676.2010.00504.x","type":"journal-article","created":{"date-parts":[[2010,4,7]],"date-time":"2010-04-07T01:26:41Z","timestamp":1270603601000},"page":"647-649","source":"Crossref","is-referenced-by-count":40,"title":["Adverse Neurologic Events Associated with Voriconazole Use in 3 Cats"],"prefix":"10.1093","volume":"24","author":[{"given":"J.M.","family":"Quimby","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine and Biomedical Sciences, Colorado State University Department of Clinical Sciences, , Fort Collins, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.B.","family":"Hoffman","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine and Biomedical Sciences, Colorado State University Department of Clinical Sciences, , Fort Collins, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Duke","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine and Biomedical Sciences, Colorado State University Department of Clinical Sciences, , Fort Collins, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Lappin","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine and Biomedical Sciences, Colorado State University Department of Clinical Sciences, , Fort Collins, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,5,1]]},"reference":[{"key":"2026020303144591200_b1","first-page":"269","article-title":"Voriconazole","volume":"67","author":"Scott","year":"2007","journal-title":"A review of its use in the management of invasive fungal infections"},{"key":"2026020303144591200_b2","author":"European Agency for the Evaluation of Medicinal Products."},{"key":"2026020303144591200_b3","first-page":"739","article-title":"Neurological adverse events to voriconazole","volume":"136","author":"Imhof","year":"2006","journal-title":"Evidence for therapeutic drug monitoring"},{"key":"2026020303144591200_b4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/13693780701541106","article-title":"First case of feline systemic Cryptococcus albidus infection","volume":"46","author":"Kano","year":"2008","journal-title":"Med Mycol"},{"key":"2026020303144591200_b5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1463-5224.2009.00673.x","article-title":"Aspergillus flavus keratomycosis in a cat treated with topical 1% voriconazole solution","volume":"12","author":"Labelle","year":"2009","journal-title":"Vet Ophthalmol"},{"key":"2026020303144591200_b6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/archneur.62.1.144","article-title":"Painful peripheral neuropathy associated with voriconazole use","volume":"62","author":"Tsiodras","year":"2005","journal-title":"Arch Neurol"},{"key":"2026020303144591200_b7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000140466","article-title":"Voriconazole-induced neuropathy","volume":"54","author":"Aksoy","year":"2008","journal-title":"Chemotherapy"},{"key":"2026020303144591200_b8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/524669","article-title":"Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes","volume":"46","author":"Pascual","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2026020303144591200_b9","first-page":"e49","article-title":"Voriconazole-induced QT interval prolongation and ventricular tachycardia","volume":"39","author":"Alkan","year":"2004","journal-title":"A non-concentration-dependent adverse effect"},{"key":"2026020303144591200_b10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/0091270005283837","article-title":"Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities","volume":"46","author":"Tan","year":"2006","journal-title":"J Clin Pharmacol"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1939-1676.2010.00504.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/24\/3\/647\/66654020\/j.1939-1676.2010.00504.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/24\/3\/647\/66654020\/j.1939-1676.2010.00504.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:14:54Z","timestamp":1770106494000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/24\/3\/647\/8447201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,1]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1939-1676.2010.00504.x","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,5]]},"published":{"date-parts":[[2010,5,1]]}}}